Welcome to our dedicated page for AvePoint SEC filings (Ticker: AVPT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
AvePoint, Inc. filings document the company’s financial results, governance matters, capital structure and public-company securities activity. Form 8-K reports furnish quarterly and annual operating results, including SaaS revenue, total revenue, annual recurring revenue and related financial-condition disclosures tied to the company’s cloud data protection business.
Proxy materials and annual meeting reports cover director elections, executive compensation votes, auditor ratification and board governance. Other filings address common stock offering activity under shelf registration materials, the company’s secondary listing context for common stock, and the removal of AvePoint warrants from Nasdaq listing and registration.
AvePoint, Inc. director and Chief Legal Officer Brown Brian Michael reported selling 10,000 shares of common stock in two open-market transactions on July 28–29, 2026, at prices of $13.06 and $13.08 per share. These sales were effected pursuant to a Rule 10b5-1 trading plan adopted on December 16, 2025. Footnotes explain that reported equity holdings, when shown, combine non-RSU common shares with vested and unvested RSUs subject to previously disclosed vesting schedules.
AvePoint, Inc. insider entity Brian M Brown Rev Trust filed to sell common stock under Rule 144. The notice covers a planned sale of 5,176 shares of AvePoint common stock, with an indicated aggregate value of $67,590.28, on or after July 29, 2026 on NASDAQ.
The shares derive from a restricted stock grant received from the issuer as compensation on July 7, 2026. Over the prior three months, the same trust reported sales of 8,369, 31,631, and 4,824 AvePoint shares for total proceeds of $108,828.96, $417,028.16, and $63,094.17, respectively.
Avepoint Inc. affiliate Brian M Brown Rev Trust filed to sell common stock under Rule 144. The trust lists 4,824 restricted shares from a 07/07/2022 restricted stock grant received from the issuer as compensation. It also reports prior sales over the past three months totaling 8,369 shares for $108,828.96 on 07/14/2026 and 31,631 shares for $417,028.16 on 07/15/2026.
AvePoint, Inc. director and chief legal officer Brian Michael Brown reported open-market sales of 40,000 shares of common stock on July 14–15, 2026, at prices of $13.00 and $13.18 per share. The transactions were executed under a Rule 10b5-1 trading plan adopted on December 16, 2025, and Brown continues to hold 819,664 shares, including vested and unvested RSUs.
AvePoint Inc. has a Form 144 notice describing a proposed sale of 31,631 shares of its common stock, with an associated value of 417,028.16, expected around July 15, 2026 on NASDAQ. Rockefeller Financial, based in Richmond, VA, is identified in connection with this transaction.
The disclosure links the securities to multiple restricted stock grants categorized as compensation from 2021–2025. It also reports a separate sale in the past three months of 8,369 AvePoint shares for 108,828.96 by Brian M Brown Rev Trust on July 14, 2026.
AVPT has a shareholder planning to sell up to 8,369 shares of common stock through Rockefeller Financial on NASDAQ, with an aggregate value of $108,828.96 and a proposed sale date of 07/14/2026. The shares come from restricted stock grants of 3,449 and 4,920 shares dated 06/05/2025 and 06/01/2025, issued as compensation.
AvePoint, Inc. director and Chief Legal Officer Brian Michael Brown exercised stock options to acquire 50,492 shares of common stock on June 18, 2026. The options had an exercise price of $1.59 per share under the company’s 2016 Equity Incentive Plan.
Following the exercise, Brown directly holds 859,664 shares of common stock, which include both regular shares and restricted stock units granted under AvePoint’s 2021 Equity Incentive Plan. He also continues to hold 2,182,807 stock options after this transaction. No shares were sold; this filing reflects a compensation-related option exercise rather than an open-market trade.
AvePoint, Inc. Executive Chairman Xunkai Gong exercised stock options to acquire a large block of common shares. On June 22, 2026, he exercised options covering 743,529 shares and another 205,913 shares of AvePoint common stock, for a total of 949,442 shares. These options, granted under AvePoint’s 2016 Equity Incentive Plan, had an exercise price of $1.34 per share and were due to expire on July 1, 2026. The filing shows no open‑market sales and indicates that these option grants have now been exercised, with Gong holding the acquired shares directly.
AvePoint, Inc. director and Chief Executive Officer Tianyi Jiang reported a tax-related share disposition. On June 12, 2026, 2,914 shares of common stock were withheld at $10.87 per share to satisfy income tax obligations tied to vested equity awards, an exempt transaction under Rule 16b-3 rather than an open-market sale. Following this withholding, Jiang directly holds 2,287,615 shares of AvePoint common stock, including both regular shares and restricted stock units that vest over time.
AvePoint, Inc. Executive Chairman Xunkai Gong reported a routine tax-related share disposition. On June 12, 2026, 3,788 shares of common stock were withheld at $10.87 per share to satisfy income tax obligations tied to equity vesting under the company’s 2021 Equity Incentive Plan.
After this non-discretionary withholding, Gong directly holds 919,590 shares of AvePoint common stock, including both non-RSU shares and vested and unvested restricted stock units subject to previously disclosed vesting schedules.